ElevateBio signs 10-year cell and gene alliance with Massachusetts hospital

The agreement provides the Massachusetts General Hospital preferred access to cell and gene therapy research

picture of

Breaking News

Bioquell opens technology centre at Americas headquarters in Pennsylvania

Facility designed to highlight and train customers on new biodecontamination solutions

CPhI MEA expert comments on booming business in the Middle East

Opportunities abound at CPhI MEA and experts anticipate regional generic companies acting as CMOs for international ...

Storability of vegetable carotene is compromised by oxygen in air

Vienna's EQ Boku reveals analysis of different processes and formulations in the production of pigment-rich carrot ...

Integrated tools for upstream process intensification: Part II

Changes to bioprocessing methodologies in the biopharmaceutical industry are being driven by the need for increased ...

Opiant Pharmaceuticals and Sanofi join forces on cannabinoid overdose

There are currently no approved treatments for acute cannabinoid overdose that is most commonly linked to ‘edibles’

Quotient gets backing from global investment firm Permira

Nottingham-based CDMO/CRO is poised to further growth in the UK and the US with new investor

A new approach to molecular imaging in cancer patients

A variety of different imaging approaches, spanning molecular to whole-body scans, have contributed greatly to our ...

University of Technology Sydney starts insulin research with US firm

PharmaCyte Biotech partnership aims to create a new version of Melligen cells for the treatment of diabetes with the ...

UK and China realises blueprint to turn research into medical treatment

Experts from across the Midlands and Jiangsu Province have gathered in Birmingham to define the opportunities and ...

Lab Innovations 2019: Simplifying laboratory procurement

Discover more than 160 leading scientific suppliers under one roof at the UK’s only lab-dedicated exhibition showcase ...

Taking a multifaceted approach to combatting superbugs

Paul Chapman, Partner at Marks & Clerk LLP, takes a look at research underway for testing a compound on Gram-negative ...

Review: CPhI and P-MEC China 2019

International visitors to the three-day event in Shanghai skyrockets more than 74% mirroring the interest for ...

Cancer drug data release set to power next wave of therapeutic discovery

The freely available data set includes a comparison of almost 1,000 cancer cell lines’ responses to 453 licensed and ...

Lab Innovations 2019 focuses on sustainability and digitisation

Industry professionals will demonstrate how to run an environmentally friendly lab, reduce costs and make funding go ...